SlideShare a Scribd company logo
Examining Prescription Drug Misuse
and Abuse from the Federal
Perspective
Frances M. Harding
Director
SAMHSA’s Center for Substance Abuse Prevention
National Rx Drug Abuse Summit
April 22, 2014
Atlanta, Georgia
SAMHSA’s Strategic Initiative #1:
Prevention of Substance Abuse and Mental Illness
Top Priorities
• Prevent substance abuse and improve well-
being in states, territories, tribes
• Establish prevention of underage drinking as a
priority issue for states, territories, tribal
entities, colleges and universities, and
communities.
• Increase public knowledge of the warning signs
for suicide and actions to take in response.
• Reduce prescription drug misuse and abuse.
Prescription Drug Abuse Affects Everyone
• Prescription medications are among the
top substances abused by 12th graders in
the past year.
• In 2011, more than 4,500 young people
per day abused a prescription drug for the
first time.
• All ages are affected.
• Older Americans
• 2009: approximately 1 U.S. infant
born per hour with signs of drug
withdrawal.
• 55 to 94 percent of neonates exposed
to opioids in utero experience
withdrawal .
Most Patients Do Not Take
Prescription Drugs as Prescribed
40%
25%
15%
20%
Urine Test Results
Prescribed drug only
Not using prescription
Other drugs
Prescription + other drugs
“ … lukewarm support among parents for
some policies that would discourage
the abuse of narcotic pain medicines.
Only 41 percent of parents said they
favor a policy that would require a
doctor's visit to obtain a refill on
these medicines, and about half do not
favor a requirement that unused pain
medicine be returned to a doctor or
pharmacy.”
National Prescription Drug Abuse
Prevention Strategy
• Prescriber and consumer
education/awareness.
– More than half, 54 percent, of
people 12 and older using
prescription pain relievers
non-medically got them from
a friend or relative for free.
• Expanded and enhanced use
of prescription drug
monitoring programs.
• Education/awareness about
safe disposal of unused
medicines.
SAMHSA’s Efforts to Prevent
Prescription Drug Abuse
• Prescription Drug Monitoring
Program grants
• Federal Drug-Free Workplace
Program
• Promotion of the DEA’s National
Take-Back Day (April 26, 2014)
• Not Worth the Risk, Even If It’s
Legal
• Prescriber Education
Date National Prevention Week 2014 Themes
Sunday, May 18 Prevention and Cessation of Tobacco Use
Monday, May 19 Prevention of Underage Drinking
Tuesday, May 20 Prevention of Prescription Drug Abuse and Marijuana Use
Wednesday, May 21 Prevention of Alcohol Use
Thursday, May 22 Prevention of Suicide
Friday, May 23 Promotion of Mental Health
Collaboration: Foundation for Success
Center for Substance Abuse
Prevention
Center for Mental Health Services
Center for Substance Abuse
Treatment
Center for Behavioral Health
Statistics and Quality
http://www.samhsa.gov

More Related Content

What's hot

Prevention of Drug Abuse
Prevention of Drug AbusePrevention of Drug Abuse
Prevention of Drug Abuse
Michelle Meyer
 
Towards a whole system strategy on prevention
Towards a whole system strategy on prevention Towards a whole system strategy on prevention
Towards a whole system strategy on prevention
Professor Jim McManus AFBPsS,FFPH,CSci, FRSB, CPsychol
 
Substance Abuse Prevention Programs for Children and Adolescents
Substance Abuse Prevention Programs for Children and AdolescentsSubstance Abuse Prevention Programs for Children and Adolescents
Substance Abuse Prevention Programs for Children and Adolescents
iretablog
 
Drugs & Society Chapter 9
Drugs & Society Chapter 9Drugs & Society Chapter 9
Drugs & Society Chapter 9
Michelle Meyer
 
EVERFI webinar: Why We Need a Paradigm Shift in the College Student Drinking ...
EVERFI webinar: Why We Need a Paradigm Shift in the College Student Drinking ...EVERFI webinar: Why We Need a Paradigm Shift in the College Student Drinking ...
EVERFI webinar: Why We Need a Paradigm Shift in the College Student Drinking ...
Michele Collu
 
Drug Use by Young People in England in 2009
Drug Use by Young People in England in 2009Drug Use by Young People in England in 2009
Drug Use by Young People in England in 2009
Public Health England
 
Mental health and substance use disorder sept 15
Mental health and substance use disorder sept 15Mental health and substance use disorder sept 15
Mental health and substance use disorder sept 15
Joan Casey
 
3 Steps to Improve Star Ratings
3 Steps to Improve Star Ratings3 Steps to Improve Star Ratings
3 Steps to Improve Star Ratings
Health Dialog
 
The Medication Adherence Challenge
The Medication Adherence ChallengeThe Medication Adherence Challenge
The Medication Adherence Challenge
Health Dialog
 
Cannabis Science & Policy Summit - Day 1 - Seiveright
Cannabis Science & Policy Summit - Day 1 - SeiverightCannabis Science & Policy Summit - Day 1 - Seiveright
Cannabis Science & Policy Summit - Day 1 - Seiveright
CannabisSummit
 
Tackling the Top 5 Barriers to Medication Adherence
Tackling the Top 5 Barriers to Medication AdherenceTackling the Top 5 Barriers to Medication Adherence
Tackling the Top 5 Barriers to Medication Adherence
Health Dialog
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
OPUNITE
 
How to Increase Medication Adherence: Critical Elements of a Patient Engageme...
How to Increase Medication Adherence: Critical Elements of a Patient Engageme...How to Increase Medication Adherence: Critical Elements of a Patient Engageme...
How to Increase Medication Adherence: Critical Elements of a Patient Engageme...
Health Dialog
 
Addressing Tobacco Dependence Video
Addressing Tobacco Dependence VideoAddressing Tobacco Dependence Video
Addressing Tobacco Dependence Video
Andy Martin
 
Rx misuse among ya including pain relievers
Rx misuse among ya including pain relieversRx misuse among ya including pain relievers
Rx misuse among ya including pain relievers
cindylibrary
 
Goldberg Chapter 16
Goldberg Chapter 16Goldberg Chapter 16
Goldberg Chapter 16
Michelle Cottrell
 
Innovative Steps That Increase Medication Adherence
Innovative Steps That Increase Medication Adherence Innovative Steps That Increase Medication Adherence
Innovative Steps That Increase Medication Adherence
Health Dialog
 
SOC 204 Goldberg Ch 16
SOC 204 Goldberg Ch 16SOC 204 Goldberg Ch 16
SOC 204 Goldberg Ch 16
Michelle Meyer
 
SOC 204 Goldberg Ch 16 Week 9
SOC 204 Goldberg Ch 16 Week 9SOC 204 Goldberg Ch 16 Week 9
SOC 204 Goldberg Ch 16 Week 9
Michelle Cottrell
 
Safe prescribing Practices Conference for Medical Professionals june 2013
Safe prescribing Practices Conference for Medical Professionals june 2013Safe prescribing Practices Conference for Medical Professionals june 2013
Safe prescribing Practices Conference for Medical Professionals june 2013
Heidi Denton
 

What's hot (20)

Prevention of Drug Abuse
Prevention of Drug AbusePrevention of Drug Abuse
Prevention of Drug Abuse
 
Towards a whole system strategy on prevention
Towards a whole system strategy on prevention Towards a whole system strategy on prevention
Towards a whole system strategy on prevention
 
Substance Abuse Prevention Programs for Children and Adolescents
Substance Abuse Prevention Programs for Children and AdolescentsSubstance Abuse Prevention Programs for Children and Adolescents
Substance Abuse Prevention Programs for Children and Adolescents
 
Drugs & Society Chapter 9
Drugs & Society Chapter 9Drugs & Society Chapter 9
Drugs & Society Chapter 9
 
EVERFI webinar: Why We Need a Paradigm Shift in the College Student Drinking ...
EVERFI webinar: Why We Need a Paradigm Shift in the College Student Drinking ...EVERFI webinar: Why We Need a Paradigm Shift in the College Student Drinking ...
EVERFI webinar: Why We Need a Paradigm Shift in the College Student Drinking ...
 
Drug Use by Young People in England in 2009
Drug Use by Young People in England in 2009Drug Use by Young People in England in 2009
Drug Use by Young People in England in 2009
 
Mental health and substance use disorder sept 15
Mental health and substance use disorder sept 15Mental health and substance use disorder sept 15
Mental health and substance use disorder sept 15
 
3 Steps to Improve Star Ratings
3 Steps to Improve Star Ratings3 Steps to Improve Star Ratings
3 Steps to Improve Star Ratings
 
The Medication Adherence Challenge
The Medication Adherence ChallengeThe Medication Adherence Challenge
The Medication Adherence Challenge
 
Cannabis Science & Policy Summit - Day 1 - Seiveright
Cannabis Science & Policy Summit - Day 1 - SeiverightCannabis Science & Policy Summit - Day 1 - Seiveright
Cannabis Science & Policy Summit - Day 1 - Seiveright
 
Tackling the Top 5 Barriers to Medication Adherence
Tackling the Top 5 Barriers to Medication AdherenceTackling the Top 5 Barriers to Medication Adherence
Tackling the Top 5 Barriers to Medication Adherence
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
 
How to Increase Medication Adherence: Critical Elements of a Patient Engageme...
How to Increase Medication Adherence: Critical Elements of a Patient Engageme...How to Increase Medication Adherence: Critical Elements of a Patient Engageme...
How to Increase Medication Adherence: Critical Elements of a Patient Engageme...
 
Addressing Tobacco Dependence Video
Addressing Tobacco Dependence VideoAddressing Tobacco Dependence Video
Addressing Tobacco Dependence Video
 
Rx misuse among ya including pain relievers
Rx misuse among ya including pain relieversRx misuse among ya including pain relievers
Rx misuse among ya including pain relievers
 
Goldberg Chapter 16
Goldberg Chapter 16Goldberg Chapter 16
Goldberg Chapter 16
 
Innovative Steps That Increase Medication Adherence
Innovative Steps That Increase Medication Adherence Innovative Steps That Increase Medication Adherence
Innovative Steps That Increase Medication Adherence
 
SOC 204 Goldberg Ch 16
SOC 204 Goldberg Ch 16SOC 204 Goldberg Ch 16
SOC 204 Goldberg Ch 16
 
SOC 204 Goldberg Ch 16 Week 9
SOC 204 Goldberg Ch 16 Week 9SOC 204 Goldberg Ch 16 Week 9
SOC 204 Goldberg Ch 16 Week 9
 
Safe prescribing Practices Conference for Medical Professionals june 2013
Safe prescribing Practices Conference for Medical Professionals june 2013Safe prescribing Practices Conference for Medical Professionals june 2013
Safe prescribing Practices Conference for Medical Professionals june 2013
 

Viewers also liked

Leonard Young CORRECT
Leonard Young CORRECTLeonard Young CORRECT
Leonard Young CORRECT
OPUNITE
 
Tuesday partnership
Tuesday partnershipTuesday partnership
Tuesday partnership
OPUNITE
 
Tue vs centpatico - van tassell
Tue vs   centpatico - van tassellTue vs   centpatico - van tassell
Tue vs centpatico - van tassell
OPUNITE
 
Tue vs ameritox -yasko-brasika_de_george
Tue vs   ameritox -yasko-brasika_de_georgeTue vs   ameritox -yasko-brasika_de_george
Tue vs ameritox -yasko-brasika_de_george
OPUNITE
 
Peter Kreiner
Peter KreinerPeter Kreiner
Peter Kreiner
OPUNITE
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday astho
OPUNITE
 
Tue gs mc cance-katz
Tue gs mc cance-katzTue gs mc cance-katz
Tue gs mc cance-katz
OPUNITE
 
Tue vs ondcp spitznas
Tue vs   ondcp spitznasTue vs   ondcp spitznas
Tue vs ondcp spitznas
OPUNITE
 
Tue gs botticelli
Tue gs botticelliTue gs botticelli
Tue gs botticelli
OPUNITE
 
Ph 4 rannizzisi
Ph 4 rannizzisiPh 4 rannizzisi
Ph 4 rannizzisi
OPUNITE
 
Tue gs collins
Tue gs collinsTue gs collins
Tue gs collins
OPUNITE
 

Viewers also liked (11)

Leonard Young CORRECT
Leonard Young CORRECTLeonard Young CORRECT
Leonard Young CORRECT
 
Tuesday partnership
Tuesday partnershipTuesday partnership
Tuesday partnership
 
Tue vs centpatico - van tassell
Tue vs   centpatico - van tassellTue vs   centpatico - van tassell
Tue vs centpatico - van tassell
 
Tue vs ameritox -yasko-brasika_de_george
Tue vs   ameritox -yasko-brasika_de_georgeTue vs   ameritox -yasko-brasika_de_george
Tue vs ameritox -yasko-brasika_de_george
 
Peter Kreiner
Peter KreinerPeter Kreiner
Peter Kreiner
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday astho
 
Tue gs mc cance-katz
Tue gs mc cance-katzTue gs mc cance-katz
Tue gs mc cance-katz
 
Tue vs ondcp spitznas
Tue vs   ondcp spitznasTue vs   ondcp spitznas
Tue vs ondcp spitznas
 
Tue gs botticelli
Tue gs botticelliTue gs botticelli
Tue gs botticelli
 
Ph 4 rannizzisi
Ph 4 rannizzisiPh 4 rannizzisi
Ph 4 rannizzisi
 
Tue gs collins
Tue gs collinsTue gs collins
Tue gs collins
 

Similar to Tue vs samhsa - harding

2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarus2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarus
profcyclist
 
Have you become your teen's drug dealer? What's in your medicine cabinet?
Have you become your teen's drug dealer? What's in your medicine cabinet?Have you become your teen's drug dealer? What's in your medicine cabinet?
Have you become your teen's drug dealer? What's in your medicine cabinet?
Amanda Edgar
 
PREVENTION OF SUBSTANCE USE AND ABUSE.pptx
PREVENTION OF SUBSTANCE USE AND ABUSE.pptxPREVENTION OF SUBSTANCE USE AND ABUSE.pptx
PREVENTION OF SUBSTANCE USE AND ABUSE.pptx
KimJoeCatacutan
 
JUVENILE DELINQUENCYTHE CORE 5EChapter 10Drug.docx
JUVENILE DELINQUENCYTHE CORE 5EChapter 10Drug.docxJUVENILE DELINQUENCYTHE CORE 5EChapter 10Drug.docx
JUVENILE DELINQUENCYTHE CORE 5EChapter 10Drug.docx
croysierkathey
 
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbinsRx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
OPUNITE
 
Drug abuse and Illicit trafficking of drugs
Drug abuse and Illicit trafficking of drugsDrug abuse and Illicit trafficking of drugs
Drug abuse and Illicit trafficking of drugs
Dr. Mallappa Shalavadi
 
Wed vs ondcp harding
Wed vs ondcp hardingWed vs ondcp harding
Wed vs ondcp harding
OPUNITE
 
Ea 3 green weiss_katzman
Ea 3 green weiss_katzmanEa 3 green weiss_katzman
Ea 3 green weiss_katzmanOPUNITE
 
Cannabis Science & Policy Summit - Day 1 - Wetterau
Cannabis Science & Policy Summit - Day 1 - WetterauCannabis Science & Policy Summit - Day 1 - Wetterau
Cannabis Science & Policy Summit - Day 1 - Wetterau
CannabisSummit
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
OPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
OPUNITE
 
Day 2 Substance Use and Abuse.pptx
Day 2 Substance Use and Abuse.pptxDay 2 Substance Use and Abuse.pptx
Day 2 Substance Use and Abuse.pptx
LornaATobias
 
Public Perspectives on Personalized Medicine: A Survey of U.S. Public Opinion
Public Perspectives on Personalized Medicine: A Survey of U.S. Public OpinionPublic Perspectives on Personalized Medicine: A Survey of U.S. Public Opinion
Public Perspectives on Personalized Medicine: A Survey of U.S. Public Opinion
PMCoalition
 
Seminar on Addiction and Substance use
Seminar on Addiction and Substance useSeminar on Addiction and Substance use
Seminar on Addiction and Substance use
Dr Rakesh Verma
 
No to drug abuse
No to drug abuseNo to drug abuse
No to drug abuse
Jelsyn Magbanua
 
Rx15 tt wed_430_1_clarkin_2vantassell-holmes
Rx15 tt wed_430_1_clarkin_2vantassell-holmesRx15 tt wed_430_1_clarkin_2vantassell-holmes
Rx15 tt wed_430_1_clarkin_2vantassell-holmes
OPUNITE
 
Substance abuse in special population
Substance abuse in special populationSubstance abuse in special population
Substance abuse in special population
manishkumargoyal7
 
Prevention
PreventionPrevention
Prevention
Michelle Meyer
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harris
OPUNITE
 

Similar to Tue vs samhsa - harding (20)

2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarus2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarus
 
Have you become your teen's drug dealer? What's in your medicine cabinet?
Have you become your teen's drug dealer? What's in your medicine cabinet?Have you become your teen's drug dealer? What's in your medicine cabinet?
Have you become your teen's drug dealer? What's in your medicine cabinet?
 
PREVENTION OF SUBSTANCE USE AND ABUSE.pptx
PREVENTION OF SUBSTANCE USE AND ABUSE.pptxPREVENTION OF SUBSTANCE USE AND ABUSE.pptx
PREVENTION OF SUBSTANCE USE AND ABUSE.pptx
 
JUVENILE DELINQUENCYTHE CORE 5EChapter 10Drug.docx
JUVENILE DELINQUENCYTHE CORE 5EChapter 10Drug.docxJUVENILE DELINQUENCYTHE CORE 5EChapter 10Drug.docx
JUVENILE DELINQUENCYTHE CORE 5EChapter 10Drug.docx
 
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbinsRx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
 
Drug abuse and Illicit trafficking of drugs
Drug abuse and Illicit trafficking of drugsDrug abuse and Illicit trafficking of drugs
Drug abuse and Illicit trafficking of drugs
 
Wed vs ondcp harding
Wed vs ondcp hardingWed vs ondcp harding
Wed vs ondcp harding
 
Ea 3 green weiss_katzman
Ea 3 green weiss_katzmanEa 3 green weiss_katzman
Ea 3 green weiss_katzman
 
Cannabis Science & Policy Summit - Day 1 - Wetterau
Cannabis Science & Policy Summit - Day 1 - WetterauCannabis Science & Policy Summit - Day 1 - Wetterau
Cannabis Science & Policy Summit - Day 1 - Wetterau
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Day 2 Substance Use and Abuse.pptx
Day 2 Substance Use and Abuse.pptxDay 2 Substance Use and Abuse.pptx
Day 2 Substance Use and Abuse.pptx
 
Public Perspectives on Personalized Medicine: A Survey of U.S. Public Opinion
Public Perspectives on Personalized Medicine: A Survey of U.S. Public OpinionPublic Perspectives on Personalized Medicine: A Survey of U.S. Public Opinion
Public Perspectives on Personalized Medicine: A Survey of U.S. Public Opinion
 
Seminar on Addiction and Substance use
Seminar on Addiction and Substance useSeminar on Addiction and Substance use
Seminar on Addiction and Substance use
 
No to drug abuse
No to drug abuseNo to drug abuse
No to drug abuse
 
Rx15 tt wed_430_1_clarkin_2vantassell-holmes
Rx15 tt wed_430_1_clarkin_2vantassell-holmesRx15 tt wed_430_1_clarkin_2vantassell-holmes
Rx15 tt wed_430_1_clarkin_2vantassell-holmes
 
Substance abuse in special population
Substance abuse in special populationSubstance abuse in special population
Substance abuse in special population
 
Prevention
PreventionPrevention
Prevention
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harris
 
PUGATCHet al ODG 2014
PUGATCHet al ODG 2014PUGATCHet al ODG 2014
PUGATCHet al ODG 2014
 

More from OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
OPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
OPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
OPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
OPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
OPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
OPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
OPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
OPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
OPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
OPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
OPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
OPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
OPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
OPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
OPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
OPUNITE
 

More from OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 

Recently uploaded

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 

Recently uploaded (20)

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 

Tue vs samhsa - harding

  • 1. Examining Prescription Drug Misuse and Abuse from the Federal Perspective Frances M. Harding Director SAMHSA’s Center for Substance Abuse Prevention National Rx Drug Abuse Summit April 22, 2014 Atlanta, Georgia
  • 2. SAMHSA’s Strategic Initiative #1: Prevention of Substance Abuse and Mental Illness Top Priorities • Prevent substance abuse and improve well- being in states, territories, tribes • Establish prevention of underage drinking as a priority issue for states, territories, tribal entities, colleges and universities, and communities. • Increase public knowledge of the warning signs for suicide and actions to take in response. • Reduce prescription drug misuse and abuse.
  • 3. Prescription Drug Abuse Affects Everyone • Prescription medications are among the top substances abused by 12th graders in the past year. • In 2011, more than 4,500 young people per day abused a prescription drug for the first time. • All ages are affected. • Older Americans • 2009: approximately 1 U.S. infant born per hour with signs of drug withdrawal. • 55 to 94 percent of neonates exposed to opioids in utero experience withdrawal .
  • 4. Most Patients Do Not Take Prescription Drugs as Prescribed 40% 25% 15% 20% Urine Test Results Prescribed drug only Not using prescription Other drugs Prescription + other drugs
  • 5. “ … lukewarm support among parents for some policies that would discourage the abuse of narcotic pain medicines. Only 41 percent of parents said they favor a policy that would require a doctor's visit to obtain a refill on these medicines, and about half do not favor a requirement that unused pain medicine be returned to a doctor or pharmacy.”
  • 6. National Prescription Drug Abuse Prevention Strategy • Prescriber and consumer education/awareness. – More than half, 54 percent, of people 12 and older using prescription pain relievers non-medically got them from a friend or relative for free. • Expanded and enhanced use of prescription drug monitoring programs. • Education/awareness about safe disposal of unused medicines.
  • 7. SAMHSA’s Efforts to Prevent Prescription Drug Abuse • Prescription Drug Monitoring Program grants • Federal Drug-Free Workplace Program • Promotion of the DEA’s National Take-Back Day (April 26, 2014) • Not Worth the Risk, Even If It’s Legal • Prescriber Education
  • 8. Date National Prevention Week 2014 Themes Sunday, May 18 Prevention and Cessation of Tobacco Use Monday, May 19 Prevention of Underage Drinking Tuesday, May 20 Prevention of Prescription Drug Abuse and Marijuana Use Wednesday, May 21 Prevention of Alcohol Use Thursday, May 22 Prevention of Suicide Friday, May 23 Promotion of Mental Health
  • 9. Collaboration: Foundation for Success Center for Substance Abuse Prevention Center for Mental Health Services Center for Substance Abuse Treatment Center for Behavioral Health Statistics and Quality http://www.samhsa.gov